Renal

Renal (Kidney) Cancer Treatment Trials

Protocol
Number

Title

ID

ARGOS
AGS
003-007

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Learn more.

NCT01582672
SLHN
2011-113
Altor
BioScience

A Phase Ib/II Trial of ALT-801 in Combination with Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Learn more.

NCT01326871